Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127021281 | 12702128 | 1 | I | 20111014 | 20120109 | 20160831 | 20160831 | PER | US-CELGENEUS-163-21880-12010834 | CELGENE | 62.77 | YR | M | Y | 70.37000 | KG | 20160831 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127021281 | 12702128 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | 25 MILLIGRAM | U | 21880 | 25 | MG | CAPSULES | ||||||
127021281 | 12702128 | 2 | SS | DECADRON | DEXAMETHASONE | 1 | Oral | 1-4,9-12,17-20 TIMES 4 CYCLES THEN DAYS 1-4 | U | U | 0 | 40 | MG | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127021281 | 12702128 | 1 | Plasma cell myeloma |
127021281 | 12702128 | 2 | Plasma cell myeloma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127021281 | 12702128 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127021281 | 12702128 | Hyperglycaemia | |
127021281 | 12702128 | Hyponatraemia | |
127021281 | 12702128 | Pain | |
127021281 | 12702128 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127021281 | 12702128 | 1 | 20110926 | 20120109 | 0 | |
127021281 | 12702128 | 2 | 20110926 | 20120109 | 0 |